Observational studyRenal failure2026
Effect of intravitreal bevacizumab on kidney function and proteinuria among diabetic patients: a prospective observational study in Asian population.
Observational study in Renal failure, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Many studies have investigated the ocular benefits of intravitreal bevacizumab but there is scarcity of literature evaluating the effects of bevacizumab on kidney function and proteinuria especially in the Asian population. This study aims to investigate the effect of intravitreal injection of bevacizumab on proteinuria and kidney function in patients with diabetic retinopathy. This prospective observational study included 50 patients with diabetes and proliferative diabetic retinopathy (PDR) and/or significant diabetic macular edema, who have received intravitreal bevacizumab injection at a tertiary care center in India. Changes in the urinary albumin-to-creatinine ratio (UACR) and estimated glomerular filtration rate (eGFR) at one month and six months after injection were measured. This study reported no significant change in eGFR and UACR at one month (
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.